FDA recently published a final guidance for industry to describe and answer questions about FDA’s use of remote regulatory assessments (RRAs) to oversee and assure compliance of FDA-regulated products, outside of the COVID-19 pandemic.
FDA’s Human Foods Program has published a proposed agenda for guidance document work to be advanced in 2025, prioritizing opiate alkaloids on poppy seeds, the use of food coloring from natural sources, and new dietary ingredient (NDI) notifications, among other topics.
USDA-FSIS released a notice in late June that it plans to extend its H5N1 Influenza A Dairy Cow Testing Program until September 30. Meanwhile, the EU released a new guidance document on preparedness, prevention, and response for avian flu in animals and food.
Advances in AI offer promising opportunities to strengthen food manufacturers' internal compliance efforts with FDA requirements. While FDA has issued written guidances on AI, primarily for drug and medical device companies, its direct application to food safety is still evolving.
In this episode of Food Safety Matters, we speak to Dr. Lane Highbarger, President of Highbarger Consulting LLC and former Regulatory Specialist and lead microbiologist in FDA's Office of Food Additive Safety, about his thoughts on the recent FDA workforce cuts instigated by the Trump Administration, and how these cuts may impact the agency's ability to ensure safe food for consumers.
FDA has released for public comment its proposed method for ranking chemicals in the food supply that will be prioritized in post-market safety assessments.
The fiscal 2026 budget request from the U.S. Department of Health and Human Services touches on infant formula, ultra-processed foods, and other HHS priorities that Food Safety Magazine has reported on.
As of May 30, 45 people across 18 states have been infected, compared to 26 people across 15 states who had been infected with the outbreak strain of Salmonella as of May 19.
Current food safety oversight is spread across multiple federal, state, and local agencies, which Cotton says decreases efficacy, creates gaps, and slows response times to potential public health risks.